139 related articles for article (PubMed ID: 35017962)
1. Phenotypic Expression of Oral Fibroblasts Derived from Oral Submucous Fibrosis: An Assay through Cell Culture.
Banerjee A; Mampilly MO; Kamath VV; Athreya V; Kotrashetti V; Srivastava KC; Shrivastava D
J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S1234-S1239. PubMed ID: 35017962
[TBL] [Abstract][Full Text] [Related]
2. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic interventions in oral submucous fibrosis: an experimental and clinical study.
Singh V; Mohammad S; Pant AP; Saimbi CS; Srivastava R
J Maxillofac Oral Surg; 2015 Jun; 14(2):278-90. PubMed ID: 26028848
[TBL] [Abstract][Full Text] [Related]
4. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
5. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
Tsai CH; Chou MY; Chang YC
J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
[TBL] [Abstract][Full Text] [Related]
6. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
7. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.
Chen CC; Huang JF; Tsai CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):604-14. PubMed ID: 7490793
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
9. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
10. Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut.
Khan I; Pant I; Narra S; Radhesh R; Ranganathan K; Rao SG; Kondaiah P
J Cell Mol Med; 2015 Oct; 19(10):2397-412. PubMed ID: 26248978
[TBL] [Abstract][Full Text] [Related]
11. [Rat model with oral submucous fibrosis induced by arecoline and mechanical stimulation].
Yang B; Fu MF; Tang ZG
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Jun; 37(3):260-264. PubMed ID: 31218858
[TBL] [Abstract][Full Text] [Related]
12. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
13. Role of autophagy and apoptosis in atrophic epithelium in oral submucous fibrosis.
Zhu B; Jiang Q; Que G; Dai Z; Wu Y
J Oral Sci; 2020 Mar; 62(2):184-188. PubMed ID: 32132327
[TBL] [Abstract][Full Text] [Related]
14. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
Chang YC; Tsai CH; Tai KW; Yang SH; Chou MY; Lii CK
Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
[TBL] [Abstract][Full Text] [Related]
15. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
16. Role of autophagy induced by arecoline in angiogenesis of oral submucous fibrosis.
Dai Z; Zhu B; Yu H; Jian X; Peng J; Fang C; Wu Y
Arch Oral Biol; 2019 Jun; 102():7-15. PubMed ID: 30951892
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
18. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
19. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
Chang YC; Yang SF; Tai KW; Chou MY; Hsieh YS
Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
[TBL] [Abstract][Full Text] [Related]
20. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
